TP53 and cancer: As a natural compound, the anti-cancer activity of parthenolide has been suggested to be due to its pro-apoptotic actions, which would occur through the activation of p53 and the increased production of reactive oxygen species (ROS) exclusively in tumor cells, while at the same time having no effect on normal cells, making PTL a promising anti-cancer drug 30.